Atherosclerosis and rheumatoid arthritis;Athérome et polyarthrite rhumatoïde

Revue de Medecine Interne

Volumn 27, Issue 2, 2006, Pages 125-136

  Soubrier, M ^a   Dougados, M ^b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Atherosclerosis; Cardiovascular disease; Rheumatoid arthritis

Indexed keywords

CORTICOSTEROID; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DISEASE ACTIVITY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; MORBIDITY; MORTALITY; PRESCRIPTION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SUPPLEMENTATION; TUNICA MEDIA;

EID: 31944441874     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2005.06.007     Document Type: Short Survey

References (87)

1. M.M. Ward Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? Arthritis Rheum. 44 2001 1467 1469
2. D.P.M. Symmons, M.A. Jones, D.L. Scott, and P. Prior Long-term mortality outcomes in patients with rheumatoid arthritis: early presenters continue to do well J. Rheumatol. 25 1998 1072 1077
3. F. Wolfe, D.M. Mitchell, J.T. Sibley, J.F. Fries, D.A. Bloch, and C.A. Williams The mortality of rheumatoid arthritis Arthritis Rheum. 37 1994 481 494
4. D.J. Watson, T. Rhodes, and H. Guess All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK general practice research dataase J. Rheumol. 30 2003 1196 1202
5. N.J. Goodson, N.J. Wiles, M. Lunt, E.M. Barrett, A.J. Silman, and D.P. Symmons Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients Arthritis Rheum. 46 2002 2010 2019
6. C. Turesson, A. Jarenros, and L. Jacobsson Increased incidence of cardiovascular disease in patients with rheumatoid arthritis-results from a community based study Ann. Rheum. Dis. 63 2004 952 955
7. F. Wolfe, B. freundlich, and W. Strauss Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis J. Rheumatol. 30 2003 36 40
8. I. Del Rincon, K. Williams, M.P. Stern, G.L. Freeman, and A. Escalante High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum. 44 2001 2737 2745
9. D.H. Solomon, E.W. Karlson, E.B. Rimm, C.C. Cannuscio, L.A. Mandl, and J.E. Manson Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 107 2003 1303 1307
10. H. Maradit-Kremers, C.S. Crowson, P.J. Nicola, K.V. Ballman, V.L. Roger, and S.J. Jacobsen Increased unrecognised coronary heart disease and sudden deaths in rheumatoid arthritis Arthritis Rheum. 52 2005 402 411
11. H. Maradit-Kremers, P.J. Nicola, C.S. Crowson, K.V. Ballman, and S.E. Gabriel Cardiovascular death in rheumatoid arthritis. A population based study Arthritis Rheum. 52 2005 722 732
12. J.N. Cohn, A.A. Quyyumi, N.K. Hollenberg, and K.A. Jamerson Surrogate markers for cardiovascular disease. Functional markers Circulation 109 Suppl IV 2004 31 46
13. G.B.J. Mancini, B. Dahlöf, and J. Diez Surrogate markers for cardiovascular disease. Structural markers Circulation 109 Suppl IV 2004 22 38
14. G. Vaudo, S. Marchesi, R. Gerli, R. Allegrucci, A. Giordano, and D. Siepi Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity Ann. Rheum. Dis. 63 2004 31 35
15. S. Hänsel, G. Lässig, F. Pistrosch, and J. Passauer Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity Atherosclerosis 170 2003 177 180
16. R. Bergholm, M. Leirisalo-Repo, S. Vehkavaara, S. Mäkimattila, M.R. Taskinen, and H. Yki-Järvinen Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis Arterioscler. Thromb. Vasc. Biol. 22 2002 1637 1641
17. C. Gonzalez-Juanatey, A. Testa, A. Garcia-Castello, C. Garcia-Porrua, J. Llorca, and M.A. Gonzalez-Gay Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor a antibody Arthritis Rheum. 51 2004 447 450
18. D. Hurlimann, A. Forster, G. Noll, F. Enseleit, R. Chenevard, and O. Distler Anti-tumor necrosis factor-a treatment improves endothelial function in patients with Rheumatoid arthritis Circulation 106 2002 2184 2187
19. A.L. McLeod, N.G. Uren, I.B. Wilkinson, D.J. Webb, S.R. Maxwell, and D.B. Northridge Non-invasive measures of pulse wave velocity correlate with coronary arterial plaque load in humans Am. J. Hypertens. 22 2004 363 368
20. E. Grey, C. Bratteli, S.P. Glasser, C. Alinder, S.M. Finkelstein, and B.R. Lindgren Reduce small artery but not large artery elasticity is an independent risk marker for cardiovascular events Am. J. Hypertens. 16 2003 265 269
21. S. Van Doormun, G. McColl, A. Jenkins, D.J. Green, and I.P. Wicks Screening for atherosclerosis in patients with rheumatoid arthritis. Comparison of two in vivo tests of vascular function Arthritis Rheum. 28 2003 72 80
22. M. Wong, L. Toh, A. Wilson, K. Rowley, C. Karschimkus, and D. Prior Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease factors and inflammation Arthritis Rheum. 48 2003 81 89
23. R. Klocke, J.R. Cockcroft, G.J. Taylor, I.R. Hall, and D.R. Blake Arterial stiffness and central blood pressure as determined by pulse wave analysis, in rheumatoid arthritis Ann. Rheum. Dis. 62 2003 414 418
24. G.L. Burke, G.W. Evans, W.A. Riley, A.R. Sharrett, G. Howard, and R.W. Barnes Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults Stroke 26 1995 386 391
25. S.W. Jonsson, C. Backman, O. Johnson, K. Karp, E. Ludström, and K.G. Sundqvist Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis J. Rheumatol. 28 2001 2597 2602
26. Y. Kumeda, M. Inaba, H. Goto, M. Nagata, Y. Henmi, and Y. Furumitsu Increased thickness of the arterial intima media detected by ultrasonography in patients with rheumatoid arthritis Arthritis Rheum. 46 2002 1489 1497
27. Y.B. Park, C.W. Ahn, H.K. Choi, S.H. Lee, B.H. In, and H.C. Lee Atherosclerosis in rheumatoid arthritis Arthritis Rheum. 46 2002 1714 1719
28. J.K. Alkaabi, M. Ho, R. Levison, T. Pullar, and J.J.F. Belch Rheumatoid arthritis and macrovascular disease Rheumatology 42 2003 292 297
29. I. Del Rincon, K. Williams, M.P. Stern, G.L. Freeman, D.H. O'Leary, and A. Escalante Association between atherosclerosis and markers of inflammation and rheumatoid arthritis and healthy subjects Arthritis Rheum. 48 2003 1833 1840
30. I. Del Rincon, R.W. Haas, S. Pogosian, and A. Escalante Lower limb arterial incompressibility and obstruction in rheumatoid arthritis Ann. Rheum. Dis. 64 2005 425 432
31. Hansson Inflammation, atherosclerosis, and coronary artery disease N. Engl. J. Med. 352 2005 1685 1695
32. V. Pasceri, and E.T.H. Yeh A tale of two diseases: Atherosclerosis and rheumatoid arthrtitis Circulation 100 1999 2124 2126
33. J.T. Willerson, and P.M. Ridker Inflammation as a cardiovascular risk factor Circulation 109 Suppl II 2004 2 10
34. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparaison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of the first cardiovascular events N. Engl. J. Med. 347 2002 1557 1565
35. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, and A. Rumley C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N. Engl. J. Med. 350 2004 1387 1397
36. P.M. Ridker, C.P. Cannon, D. Morrow, N. Rifai, L.M. Rose, and C.H. McCabe C-reactive protein levels and outcomes after statin therapy N. Engl. J. Med. 352 2005 20 28
37. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, T. Crowe, W.J. Sasiela, and J. Tsai Statin therapy, LDL cholesterol, C-reactive protein, and coronary disease N. Engl. J. Med. 352 2005 29 38
38. N. Sattar, D.W. McCarey, H. Capell, and I.B. McInnes Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2003 2957 2963
39. A. Boulogne, and M.C. Vantygbem Epidemiologic data and screening criteria of the metabolic syndrome Presse Med. 33 2004 662 665
40. J.P. Despres, B. Lamarche, and P. Mauriege Hyperinsulinemia as an independent risk factor for ischaemic heart disease N. Engl. J. Med. 334 1996 952 957
41. P.H. Dessein, A.E. Stanwix, and B.I. Joffe Cardiovascular risk in rheumatoid arthritis vs osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis Arthritis Res. 4 2002 R5
42. H. Dessein, B.I. Joffe, and A.E. Stanwix Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis J. Rheumatol. 2003
43. A. Boulogne, and M.C. Vantygbem Insulin resistance physiopathology Presse Med. 33 2004 666 672
44. S. Wallberg-Johnsson, M. Cederfelt, and S. Rantapaa-Dahlqvist Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an eight year followup study J. Rheumatol. 27 2000 71 75
45. A. McEntegart, H.A. Capell, D. Creran, A. Rumley, M. Woodward, and G.D.O. Lowe Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis Rheumatol. 40 2001 640 644
46. D.H. Solomon, G.C. Curhan, E.B. Rimm, C.C. Cannuscio, and E.W. Karlson Cardiovascular risk factors in women with and without rheumatoid arthritis Arthritis Rheum. 50 2004 3444 3449
47. H.M. Kremers, P.J. Nicola, C.S. Crowson, K.V. Ballman, and S.E. Gabriel Pronostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis Arthritis Rheum. 50 2004 3450 3457
48. M. Boers, M.T. Nurmohamed, C.J. Doelman, L.R. Lard, A.C. Verhoeven, and A.E. Voskuyl Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis Ann. Rheum. Dis. 62 2003 842 845
49. Y.B. Park, S.K. Lee, W.K. Lee, C.H. Suh, C.W. Lee, and C.H. Lee Lipid profiles in untreated patients with rheumatoid arthritis J. Rheumatol. 26 1999 1701 1704
50. E. Hurt-Camejo, S. Paredes, L. Massana, G. Camejo, P. Sartipy, and B. Rosengren Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile Arthritis Rheum. 44 2001 2761 2767
51. W. Khovidhunki, R.A. Memon, K.R. Feingold, and C. Grunfeld Infection and inflammation-induced proatherogenic changes of lipoproteins J. Infect. Dis. 181 Suppl3 2000 S462 S472
52. J. Danesh, R. Collins, and R. Peto Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies Circulation 102 2000 1082 1085
53. S. Rantapaa-Dahlqvist, S. Wallberg-Jonsson, and G. Dahlen Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis Ann. Rheum. Dis. 50 1991 366 368
54. Y. Asanuma, S. Kawai, H. Aoshima, J. Kaburaki, and Y. Mizushima Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis Arthritis Rheum. 42 1999 443 447
55. Y.B. Park, H.K. Choi, M.Y. Kim, W.K. Lee, J. Song, and G.K. Kim Effect of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study Am. J. Med. 113 2002 188 193
56. K.L. Svenson, H. Lithell, R. Hallgren, and B. Vessby Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment Arch. Intern. Med. 147 1987 1912 1916
57. R. Munro, E. Morrison, A.G. McDonald, J.A. Hunter, R. Madhok, and H.A. Capell Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis Ann. Rheum. Dis. 56 1997 374 377
58. E. Gauza, K. Gauza, U. Hanusch-Enserer, M. Etemad, A. Dunky, and K. Kostner Intravenous anti-TNF-a antibody therapy leads to elevated triglyceride and reduced LDL cholesterol levels in patients with rheumatoid and psoriatic arthritis Wien. Klin. Wochenschr. 114 2002 1004 1007
59. M. Vis, M.T. Nurmohamed, G. Wolbink, A.E. Voskuyl, M.H.M.T. de Koning, and R.J. van de Stadt Short term effects of Infliximab on the lipid profile in patients with rheumatoid arthritis J. Rheum. 32 2005 252 255
60. C. Popa, M.G. Netea, T. Radstake, J.W.M. Van der Meer, A.F.H. Stalenhoef, and P.L.C.M. van Riel Influence of anti-tumor necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis Ann. Rheum. Dis. 64 2005 303 305
61. S.A. Albano, E. Santana-Sahagun, and M.H. Weisman Cigarette smoking and rheumatoid arthritis Semin. Arthritis Rheum. 31 2001 146 159
62. P. Stolt, C. Bengtsson, B. Nordmark, S. Lindblad, I. Lundberg, and L. Klareskog Quantification of the influence of cigarette smoking on rheumatoid arthritis: result from a population based study, using incident cases Ann. Rheum. Dis. 62 2003 835 841
63. E. Krishan Smoking, gender and rheumatoid arthritis epidemiological clues to etiology: results from the behavorial risk factor surveillance system J. bone spine 70 2003 496 502
64. B.J. Harrison Influence of cigarette smoking on disease outcome in rheumatoid arthritis Curr. Opin. Rheumatol. 14 2002 93 97
65. R. Clarke, L. Daly, K. Robinson, E. Naughten, S. Cahalane, and B. Fowler Hyperhomocysteinemia: an independent risk factor for vascular disease N. Engl. J. Med. 324 1991 1149 1155
66. A. Hernanz, A. Plaza, E. Martin-Mola, and E. de Miguel Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women Clin. Biochem. 32 1999 65 70
67. C.J. Haagsma, H.J. Blom, P.L. Van Riel, M.A. Van 't Hof, B.A. Giesendorf, and D. van Oppenraaij-Emmerzaal Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis Ann. Rheum. Dis. 58 1999 79 84
68. R.B.M. Landeẃ, E.E.M. van den Borne, F.C. Breedveld, and B.A.C. Dijkmans Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity Lancet 355 2000 1616 1617
69. O.K. Jensen, C. Rasmussen, F. Mollerup, P.B. Christensen, H. Hansen, and S. Ekelund Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation J. Rheumatol. 29 2002 1615 1618
70. L. Wei, T.M. MacDonald, and B.R. Walker Taking glucocorticoid by prescription is associated with subsequent cardiovascular disease Ann. Intern. Med. 141 2004 764 770
71. P.C. Souverein, A. Berard, T.P. Van Staa, C. Cooper, A.C.G. Egberts, and H.G.M. Leufkens Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study Heart 90 2004 859 865
72. I. Del Rincon, D.H. O'Leary, R.W. Haas, and A. Escalante Effect of glucocorticoids on the arteries in rheumatoid arthritis Arthritis Rheum. 50 2004 3813 3822
73. R.S. Bresalier, R.S. Sandler, H. Houan, J.A. Bologneses, B. Oxenius, and K. Horgan Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N. Engl. J. Med. 352 2005 1092 1102
74. S.D. Solomon, J.J.V. McMurray, M.A. Pfeffer, J. Wittes, R. Fowler, and P. Finn Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N. Engl. J. Med. 2005 352
75. Afssaps Ścurit́ d'emploi des coxibs:: nouvelles contre-indications et mises en garde concernant le risqú cardiovasculaire Fevrier 2005
76. D.H. Campen, D. Graham, C. Cheetham, S. Shoor, G. Levy, and R. Hui Risk of acute cardiac events among patients treated with cyclooxygenase-2 selective and non-selective-non steroidal anti-inflammatory drugs Arthritis Rheum. 50 Suppl 2004 S657
77. T. Kurth, R.J. Glynn, A.M. Walker, K.A. Chan, J.E. Buring, and C.H. Hennekens Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs Circulation 108 2003 1191 1195
78. D.H. Solomon, E.W. Karlson, and G. Curhan Cardiovascular care and cancer screening in female nurses with and without rheumatoid arthritis Arthritis Rheum. 51 2004 429 432
79. H.K. Choi, M.A. Herman, J.D. Seeger, J.M. Robins, and F. Wolfe Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 2002 1173 1177
80. S. Prodanowich, F. Ma, J.R. Taylor, C. Prezon, T. Fasihi, and R.S. Kirsner Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis J. Am. Acad. Dermatol. 52 2005 262 267
81. L.T.H. Jacobsson, C. Turesson, A. Gülfe, M. Cmkic, I.F. Petersson, and T. Saxne Low incidence of first cardiovascular event in rheumatoid arthritis patients treated with TNF-blockers Arthritis Rheum. 48 Suppl 2003 S241
82. N. Sattar, and I.B. McInnes Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions Curr. Opin. Rheumatol. 17 2005 286 292
83. J.P.J. Halcox, and J.E. Deanfield Beyond the laboratory. Clinical implications for statin pleitropy Circulation 109 suppl II 2004 42 48
84. D. McCarey, I. McInnes, R. Madhok, R. Hampson, O. Scherbakova, and I. Ford Trial of atorvastatin in rheumatoid arthritis (TARA): double blind, randomized placebo-controlled trial Lancet 363 2004 2015 2021
85. S. Van Doornum, G. McColl, and I.P. Wicks Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis Ann. Rheum. Dis. 63 2004 1571 1575
86. Anaes Ḿthodes d'́valuation du risqú cardiovasculaire global Juin 2004
87. Afssaps Prise en charge th́rapeutique du patient dyslipid́mique Mars 2005